WinstonWınston
Evonik Industries AG logo

Evonik Industries AG

EVKIF
43
Chemicals - Specialty · Basic Materials
Price
$20.63
+1.92 (+10.24%)
Market Cap
$9.61B
Exchange
Other OTC
Winston Score
43
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 9, 2026 · filings through Jun 30, 2026

Evonik Industries is a German specialty chemicals company that makes ingredients and materials used in everyday products like cosmetics, animal feed, tires, and medicines. Its core products include amino acids (used in livestock nutrition), specialty additives for coatings and plastics, and active ingredients for pharmaceuticals and personal care. It is one of the largest specialty chemicals companies in the world and is majority-owned by a German public foundation.

Evonik earns money by selling specialty chemical products to industrial customers across sectors like agriculture, automotive, healthcare, and consumer goods. It operates globally, with a strong presence in Europe, North America, and Asia, generating roughly €15 billion in annual revenue. Its competitive edge comes from proprietary production processes and deep customer relationships, but the business faces ongoing pressure from high European energy costs and weak industrial demand, both of which squeeze margins and have kept returns on capital low in recent periods.

Winston Score History

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 466.0M (2021) → 466.0M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
24.7%
Thin — 24.7% gross margin
Operating Margin
12.4%
Healthy — 12.4% operating margin
ROCE
3.9%
Weak — 3.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-3.9%
Shrinking sales (-3.9% YoY)
EPS YoY
-71.6%
Earnings shrinking (-71.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
1346%
Turns 1346% of profit into real cash
FCF Margin
6.0%
Thin free cash flow (6.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.57
Conservative — low debt load (0.57)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
79.8x
Expensive — P/E 79.8

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+68.0
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (79.8 → 11.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
5.59%
Healthy income — 5.59% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend Growth
+26.2%
Dividend growing fast (26.2% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial